Literature DB >> 7846462

Clinical diagnoses in 216 insomnia patients using the International Classification of Sleep Disorders (ICSD), DSM-IV and ICD-10 categories: a report from the APA/NIMH DSM-IV Field Trial.

D J Buysse1, C F Reynolds, D J Kupfer, M J Thorpy, E Bixler, R Manfredi, A Kales, A Vgontzas, E Stepanski, T Roth.   

Abstract

Three diagnostic classifications for sleep disorders have been developed recently: the International Classification of Sleep Disorders (ICSD), the Diagnostic and Statistical Manual, 4th edition (DSM-IV), and the International Classification of Diseases, 10th edition (ICD-10). No data have yet been published regarding the frequency of specific diagnoses within these systems or how the diagnostic systems relate to each other. To address these issues, we examined clinical sleep disorder diagnoses (without polysomnography) in 257 patients (216 insomnia patients and 41 medical/psychiatric patients) evaluated at five sleep centers. A sleep specialist interviewed each patient and assigned clinical diagnoses using ICSD, DSM-IV and ICD-10 classifications. "Sleep disorder associated with mood disorder" was the most frequent ICSD primary diagnosis (32.3% of cases), followed by "Psychophysiological insomnia" (12.5% of cases). The most frequent DSM-IV primary diagnoses were "Insomnia related to another mental disorder" (44% of cases) and "Primary insomnia" (20.2% of cases), and the most frequent ICD-10 diagnoses were "Insomnia due to emotional causes" (61.9% of cases) and "Insomnia of organic origin" (8.9% of cases). When primary and secondary diagnoses were considered, insomnia related to psychiatric disorders was diagnosed in over 75% of patients. The more narrowly defined ICSD diagnoses nested logically within the broader DSM-IV and ICD-10 categories. We found substantial site-related differences in diagnostic patterns. These results confirm the importance of psychiatric and behavioral factors in clinicians' assessments of insomnia patients across all three diagnostic systems. ICSD and DSM-IV sleep disorder diagnoses have similar patterns of use by experienced clinicians.

Entities:  

Mesh:

Year:  1994        PMID: 7846462     DOI: 10.1093/sleep/17.7.630

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  36 in total

1.  Addictive evidence.

Authors:  Jonathan A E Fleming; Charles H Samuels; James MacFarlane; Rachel Morehouse
Journal:  Can Fam Physician       Date:  2008-03       Impact factor: 3.275

2.  Cognitive Behavioral Insomnia Therapy for Those With Insomnia and Depression: A Randomized Controlled Clinical Trial.

Authors:  Colleen E Carney; Jack D Edinger; Maragatha Kuchibhatla; Angela M Lachowski; Olya Bogouslavsky; Andrew D Krystal; Colin M Shapiro
Journal:  Sleep       Date:  2017-04-01       Impact factor: 5.849

3.  Association between physical activity and insomnia symptoms in rural communities of southeastern Missouri, Tennessee, and Arkansas.

Authors:  Jen Jen Chang; Grace W Pien; Katherine A Stamatakis; Ross C Brownson
Journal:  J Rural Health       Date:  2012-11-20       Impact factor: 4.333

4.  Normal and abnormal sleep in the elderly.

Authors:  Jana R Cooke; Sonia Ancoli-Israel
Journal:  Handb Clin Neurol       Date:  2011

Review 5.  Impact of insomnia on health-related quality of life.

Authors:  C Idzikowski
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

6.  Daytime symptom patterns in insomnia sufferers: is there evidence for subtyping insomnia?

Authors:  Maria M Sánchez-Ortuño; Jack D Edinger; James K Wyatt
Journal:  J Sleep Res       Date:  2011-01-04       Impact factor: 3.981

7.  Evaluating DSM-5 Insomnia Disorder and the Treatment of Sleep Problems in a Psychiatric Population.

Authors:  Lee Seng Esmond Seow; Swapna Kamal Verma; Yee Ming Mok; Sunita Kumar; Sherilyn Chang; Pratika Satghare; Aditi Hombali; Janhavi Vaingankar; Siow Ann Chong; Mythily Subramaniam
Journal:  J Clin Sleep Med       Date:  2018-02-15       Impact factor: 4.062

8.  Relationship between sleep disturbance and recovery in patients with borderline personality disorder.

Authors:  David T Plante; Frances R Frankenburg; Garrett M Fitzmaurice; Mary C Zanarini
Journal:  J Psychosom Res       Date:  2013-02-11       Impact factor: 3.006

9.  A dietary supplement to improve the quality of sleep: a randomized placebo controlled trial.

Authors:  Catherine Cornu; Laurent Remontet; Florence Noel-Baron; Alain Nicolas; Nathalie Feugier-Favier; Pascal Roy; Bruno Claustrat; Mitra Saadatian-Elahi; Behrouz Kassaï
Journal:  BMC Complement Altern Med       Date:  2010-06-22       Impact factor: 3.659

10.  Eszopiclone: its use in the treatment of insomnia.

Authors:  Jaime M Monti; S R Pandi-Perumal
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.